First human case of Shamonda virus confirmed in France

The French ministries of Health and Agriculture announced on October 22, 2026 that they had detected the first human case in the world of infection with Shamonda virus, an arbovirus — meaning one transmitted by arthropods such as mosquitoes or midges — until now documented exclusively in farm animals, particularly cattle. The European Centre for Disease Prevention and Control (ECDC) confirmed that this is indeed the first known human detection, involving a patient in severe condition.

Shamonda virus belongs to the family of viruses transmitted by animal vectors and had until now been associated mainly with episodes of disease in livestock, with reports in various areas of the world over the years. The transition to a confirmed human case therefore represents a new event for European epidemiological surveillance, and for this reason required a joint communication between the French health and agricultural authorities: animal-to-human transmission, when confirmed for the first time, requires verification of contagion mechanisms, at-risk populations and possible circulation of the virus among vectors present in the territory.

At present the news comes from a single origin — the communication from the French ministries, taken up and confirmed by the ECDC — and no independent confirmations are available. No details have been disclosed, in the material released so far, about the patient’s age, area of residence or circumstances of exposure, elements which in any case would not be reportable under the rules protecting identifiable individuals applicable to this section.

The fact that this is a single case, however confirmed by two institutional sources, does not at present allow it to be established whether this is an isolated event or the beginning of broader circulation of the virus in humans. Epidemiological surveillance of this type of event typically requires weeks before further cases can be excluded or confirmed, through contact tracing and analysis of the vectors present in the area where exposure occurred.

It remains to be clarified, in forthcoming updates from the French and European health authorities, whether other suspected cases have been identified, what the probable route of transmission was, and what veterinary and health surveillance measures have been activated in the affected territory.